Skip to main content
. Author manuscript; available in PMC: 2021 Aug 11.
Published in final edited form as: J Parkinsons Dis. 2021;11(3):1057–1065. doi: 10.3233/JPD-202497

Table 3.

Barriers to Vaccination Based on Responses to Adapted Vaccine Hesitancy Survey

SAGE Vaccine Hesitancy Survey Question responses (%) Full cohort
(n = 143)
Homebound
(n = 41)
Ambulatory
(n = 102)
p
Can vaccines protect people from serious disease? 0.69
 No 5 (3.5) 2 (4.9) 3 (2.9)
 I don’t know 15 (10.5) 5 (12.2) 10 (9.8)
Have the people who live with you been vaccinated with all the recommended vaccines? 0.11
 No 19 (13.3) 6 (14.6) 13 (12.8)
 I don’t know 53 (37.1) 20 (48.8) 33 (32.4)
Have you ever been hesitant about a vaccine?
 Yes 35 (24.5) 6 (14.6) 29 (28.4) 0.08
Have you ever refused a vaccine?
 Yes 19 (13.3) 4 (9.8) 15 (14.7) 0.59
Are there any reasons you think people should not be vaccinated?
 Yes 46 (32.2) 8 (19.5) 38 (37.3) 0.06
Are there any reasons you think people with PD should not be vaccinated?
 Yes 7 (4.9) 3 (7.3) 4 (3.9) 0.46
Do healthcare providers recommend vaccines for people with PD? 0.06
 No 18 (12.6) 9 (22.0) 9 (8.8)
 I don’t know 45 (31.5) 9 (22.0) 36 (35.3)
Perceived barriers to vaccination
 Distance to clinic 2 (1.4) 2 (4.9) 0 (0.0) 0.08
 Time needed to get to clinic 3 (2.1) 0 (0.0) 3 (2.9) 0.56
 Difficulty traveling to clinic 6 (4.2) 5 (12.2) 1 (1.0) < 0.01
 Cost 4 (2.8 1 (2.4) 3 (2.9) 1.00

Bolded p-values indicate statistical significance.